CYP19A1 and endometrial cancer: Aromatase is an enzyme involved in the biosynthesis of estrogens, and aromatase inhibitors are a way to prevent or treat estrogen-mediated carcinogenesis, including breast, ovarian, and endometrial cancers [86].